He, Q.; Bu, F.; Wang, Q.; Li, M.; Lin, J.; Tang, Z.; Mak, W.Y.; Zhuang, X.; Zhu, X.; Lin, H.-S.;
et al. Examination of the Impact of CYP3A4/5 on Drug–Drug Interaction between Schizandrol A/Schizandrol B and Tacrolimus (FK-506): A Physiologically Based Pharmacokinetic Modeling Approach. Int. J. Mol. Sci. 2022, 23, 4485.
https://doi.org/10.3390/ijms23094485
AMA Style
He Q, Bu F, Wang Q, Li M, Lin J, Tang Z, Mak WY, Zhuang X, Zhu X, Lin H-S,
et al. Examination of the Impact of CYP3A4/5 on Drug–Drug Interaction between Schizandrol A/Schizandrol B and Tacrolimus (FK-506): A Physiologically Based Pharmacokinetic Modeling Approach. International Journal of Molecular Sciences. 2022; 23(9):4485.
https://doi.org/10.3390/ijms23094485
Chicago/Turabian Style
He, Qingfeng, Fengjiao Bu, Qizhen Wang, Min Li, Jiaying Lin, Zhijia Tang, Wen Yao Mak, Xiaomei Zhuang, Xiao Zhu, Hai-Shu Lin,
and et al. 2022. "Examination of the Impact of CYP3A4/5 on Drug–Drug Interaction between Schizandrol A/Schizandrol B and Tacrolimus (FK-506): A Physiologically Based Pharmacokinetic Modeling Approach" International Journal of Molecular Sciences 23, no. 9: 4485.
https://doi.org/10.3390/ijms23094485
APA Style
He, Q., Bu, F., Wang, Q., Li, M., Lin, J., Tang, Z., Mak, W. Y., Zhuang, X., Zhu, X., Lin, H.-S., & Xiang, X.
(2022). Examination of the Impact of CYP3A4/5 on Drug–Drug Interaction between Schizandrol A/Schizandrol B and Tacrolimus (FK-506): A Physiologically Based Pharmacokinetic Modeling Approach. International Journal of Molecular Sciences, 23(9), 4485.
https://doi.org/10.3390/ijms23094485
